Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02048722
Title Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Northwestern University
Indications

angiosarcoma

Therapies

Regorafenib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Sarcoma Oncology Center Santa Monica California 90403 United States Details
Mayo Clinic in Florida Jacksonville Florida 32224-9980 United States Details
Northwestern University Chicago Illinois 60611 United States Details
University of Iowa Iowa City Iowa 52246 United States Details
University of Minnesota Medical Center-Fairview Minneapolis Minnesota 55455 United States Details
Mayo Clinic Rochester Minnesota 55905 United States Details
Washington University-St. Louis Saint Louis Missouri 63110 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field